Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. (Q52545680)

3 May 2018

title

Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. (English)

1 reference

3 May 2018

0 references

5

George P Noon

1 reference

3 May 2018

8

Jeffrey A Towbin

1 reference

3 May 2018

author name string

Matteo Vatta

1

1 reference

3 May 2018

Sonny J Stetson

2

1 reference

3 May 2018

Alejandro Perez-Verdia

3

1 reference

3 May 2018

Mark L Entman

4

1 reference

3 May 2018

Guillermo Torre-Amione

6

1 reference

3 May 2018

Neil E Bowles

7

1 reference

3 May 2018

language of work or name

English

0 references

publication date

1 March 2002

1 reference

3 May 2018

published in

The Lancet

1 reference

3 May 2018

volume

359

1 reference

3 May 2018

issue

9310

1 reference

3 May 2018

page(s)

936-941

1 reference

3 May 2018

Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Enhanced deposition of predominantly type I collagen in myocardial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Dystrophin analysis in idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Actin mutations in dilated cardiomyopathy, a heritable form of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Desmin mutation responsible for idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Results with the Novacor assist system and evaluation of long-term assistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Recurrent remodeling after ventricular assistance: is long-term myocardial recovery attainable?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Regression of cellular hypertrophy after left ventricular assist device support

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

The dystrophinopathies: an alternative to the structural hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908026-1

7 January 2021

10.1016/S0140-6736(02)08026-1

Identifiers

DOI

1 reference

3 May 2018

1 reference

3 May 2018